61 results
DEFM14A
77i75c2nz3yiqu
18 Jan 24
Proxy related to merger
7:44am
PRER14A
up0kcy4id3w35n ft9
18 Jan 24
Preliminary revised proxy
7:19am
PREM14A
t7qhftqy6q6 umlj
5 Jan 24
Preliminary proxy related to merger
5:13pm
DEFA14A
tpgf1d0tg4t m7zi0
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
1vhbvgn88 qj7iv
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-2.1
pi2kd7 0ue4ps
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
1vkriu6bbus9
3 May 23
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
6:39am